ArticleRSC advances2024

Galactosyl BODIPY-based nanoparticles as a type-I photosensitizer for HepG2 cell targeted photodynamic therapy.

Jin-Yu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.